cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Anggi
Contact Email
anggi.restyana@unik-kediri.ac.id
Phone
+6285655000039
Journal Mail Official
jalapa@unik-kediri.ac.id
Editorial Address
Program Studi Farmasi, Fakultas Ilmu Kesehatan, Universitas Kadiri Jl Selomangleng No. 1 Pojok, Mojoroto, Kota Kediri
Location
Kota kediri,
Jawa timur
INDONESIA
Jurnal Inovasi Farmasi Indonesia
Published by Universitas Kadiri
ISSN : 27212254     EISSN : 27162826     DOI : 10.30737/jafi
Core Subject : Health, Science,
Decision Sciences, Operations Research & Management Health Professions Immunology & microbiology Medicine & Pharmacology Public Health
Jurnal Inovasi Farmasi Indonesia merupakan jurnal original yang diterbitkan program studi farmasi dalam berbagai bidang kefarmasian yang bertujuan untuk selalu memberikan inovasi penelitian-penelitian. Jurnal Inovasi Farmasi Indonesia teregistrasi oleh LIPI dan terbit setiap 6 Bulan pada Bulan Juni dan Desember. Jurnal Inovasi Farmasi Indonesia lahir pada tanggal 14 November 2019. dengan sistem jurnal terbuka. Jurnal Inovasi Farmasi Indonesia menerima naskah berbahasa inggris maupun Indonesia dengan abstrak dalam dua bahasa (Indonesia dan Inggris). Kami membuka luas pada berbagai bidang seperti Teknologi Farmasi, Farmakologi dan Toksikologi, Biologi Farmasi, Imunologi, Bakteriologi, Pengobatan Bahan Alam, Farmasi Klinis, Komunitas dan Sosial Farmasi.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Ilmu Farmasi
Articles 82 Documents
 5   6   7   8   9 
Profil Terapi dan Evaluasi Peresepan Pasien Covid-19 Rawat Jalan Di RS Wafa Husada Malang: Therapy Profile and Prescription Evaluation for Covid-19 Out Patients at Wafa Husada Hospital Malang Ilmi , Tsamrotul; Probosiwi , Neni; Sukmawati, Datin An Nisa; Nurkamah, Siti; Lestari, Sri; Tandela, Tantik
Jurnal Inovasi Farmasi Indonesia (JAFI) Vol. 6 No. 2 (2025): Volume 6, No.2 Juni 2025
Publisher : Universitas Kadiri

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30737/jafi.v6i2.6529

Abstract

Treatment of COVID-19 patients is differentiated based on the degree of symptoms. The purpose of this study was to determine the therapeutic profile and appropriateness of prescriptions for outpatient COVID-19 at Wava Husada Hospital for the period January–July 202, based on the COVID-19 Management Protocol Book, Edition 2, 2021 and the Hospital Formulary. The research method was a retrospective descriptive observational study with a purposive sampling technique. The research instruments were medical records from SIMRS and patient prescriptions. The results showed that most patients were male (53%), aged 18-44 years (60%). The treatment profile of COVID-19 patients with asymptomatic and mild symptoms, according to therapeutic class, were vitamins (40.3%), cough and cold (12.7%), antipyretic analgesics (9.1%), supplements (8.2%), and macrolide antibiotics (7.6%). The most common types of drugs were vitamin C 500 mg non-acidic (11.8%), vitamin E 400 IU (9.8%) and vitamin D 5000 IU (8.1%). The prescription compliance is 92% of drugs according to the COVID-19 Management Protocol Book Ed. 2 of 2021 and the rationality compliance is 79%. The prescription compliance according to the Hospital Formulary has been fulfilled 100%.
Analisis Profil Terapi dan Evaluasi Kualitas Peresepan Pada Pasien COVID-19 Rawat Inap di Rs X Jawa Tengah: Therapeutic Profile Analysis and Prescription Quality Assessment for COVID-19 Inpatients Hospital X in East Java Mawarni, Okky Intan; winartiana, Winartiana; Putri, Elsa Mahardika; Pratiwi, Maharani Dwi; Prabowo, Pulung; Ratnanigrum, Elly Rakhmawati
Jurnal Inovasi Farmasi Indonesia (JAFI) Vol. 6 No. 2 (2025): Volume 6, No.2 Juni 2025
Publisher : Universitas Kadiri

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30737/jafi.v6i2.6530

Abstract

COVID-19, caused by SARS-CoV-2, has a high transmission and mortality rate, The variability in therapies administered to patients necessitates an evaluation of treatment patterns among COVID-19 patients to ensure effective therapeutic outcomes. This study aims to analyze the therapy profiles and evaluate prescription patterns of hospitalized patients at General Hospital X, Central Java, based on the COVID-19 Management Protocol, 2nd edition (January 2021). A retrospective descriptive method with purposive sampling was applied to 100 hospitalized COVID-19 patients in 2022. The results showed that the majority of patients were male (55%), aged 40–59 years (45%), had moderate disease severity (77%), a treatment duration of 1–10 days (89%), and a recovery rate of 62%. The most frequently used drug therapies included respiratory medications (19%), gastrointestinal drugs (17%), vitamins (16%), antibiotics (11%), and antivirals (11%). Prescription evaluation revealed 100% drug suitability, 100% correct dosage, 97% appropriate dosing intervals, and 92% correct duration of administration.

Page 9 of 9 | Total Record : 82

 5   6   7   8   9 

Filter by Year

2019 2025


Reset
Filter By Issues
All Issue Vol. 6 No. 2 (2025): Volume 6, No.2 Juni 2025 Vol. 6 No. 1 (2024): Volume 6 No.1 (2024) Vol. 6 No. 1 (2024): Volume 6, No.1, Desember 2024 Vol. 5 No. 2 (2024): Volume 5 Nomor 2 Juni 2024 Vol. 5 No. 1 (2023): Jurnal Inovasi Farmasi Indonesia (JAFI). Volume 5, No. 1 (2023) Vol. 4 No. 2 (2023): Jurnal Inovasi Farmasi Indonesia (JAFI) Vol 4, No 1 (2022): Vol. 4 No.1 Desember 2022 Vol. 4 No. 1 (2022): Vol. 4 No.1 Desember 2022 Vol 3, No 2 (2022): Vol. 3 No. 2 Juni 2022 Vol 3, No 1 (2021): Vol.3 No.1 Desember 2021 Vol 2, No 2 (2021): Juli 2021 Vol 2, No 1 (2020): Vol. 2 No. 1 Desember 2020 Vol 1, No 2 (2020): Vol. 1 No. 2 Juni 2020 Vol 1, No 1 (2019): Desember 2019 More Issue